GW433908 open label study for subjects with HIV who are treatment experienced, on a failing regimen or intolerant to current therapy and sensitive to GW433908

Trial Profile

GW433908 open label study for subjects with HIV who are treatment experienced, on a failing regimen or intolerant to current therapy and sensitive to GW433908

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Sep 2006

At a glance

  • Drugs Fosamprenavir; Ritonavir
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 05 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top